NOV 05, 2020 1:45 PM PST

New insights on pancreatic ductal adenocarcinoma

New research published this week in Cell from scientists at NYU Grossman School of Medicine, the Department of Radiation Oncology at NYU Langone Health, and Perlmutter Cancer Center details the mechanism by which pancreatic cancer cells avoid starvation. The study looks specifically at the relationship between pancreatic ductal adenocarcinoma cancer tumors and dense tissue growth.

Pancreatic ductal adenocarcinoma, known by its acronym PDAC, has a five-year survival rate of less than 10%, making it the most fatal pancreatic cancer. Approximately  47,050 people will die of pancreatic cancer in 2020, according to the American Cancer Society.

The NYU scientists conducted experiments in cancer cells, mice, and human tissue samples. They determined that when pancreatic cancer cells are starving, they release a protein known as nerve growth factor which triggers nerve cell axons to secrete serine into tumors, providing energy to the cancer cells so they can continue replicating. Serine is an amino acid that acts as a building block for protein growth.

"Our study offers more proof that pancreatic cancers are remarkable metabolic scavengers, which contributes to their deadliness," says corresponding author Alec Kimmelman, MD, PhD, the Chair of the Department of Radiation Oncology at NYU Langone. "The ability of nerves to funnel nutrients from the bloodstream to the more austere pancreatic tumor microenvironment is a fascinating adaptation, and could lead to therapeutic approaches that interfere with this unique flexibility."

This mechanism by which pancreatic cancer cells manipulate nerve cells to rescue them from starvation has been shown in previous investigations. However, this is the first study to show that nerve cell axons, the extensions of nerve cells, also assist cancer cells and tumors metabolically.

Future studies will contemplate the potential of introducing serine-free diets in order to target nerve cell axons and the nutrients that they provide for pancreatic cancer cells. The team has already begun such experiments, showing that mice that received serine-free diets had a 50% slower tumor growth of PDAC tumors. Combining this nutritional therapy with a drug known as LOXO-101 that inhibits the ability of neurons to extend their axons into tumors showed an additional slowing of tumor growth by another 50%.

"As TRK inhibitors are approved in the treatment of some cancers, they might have value in combination with a low serine diet following surgery in the perhaps 40 percent of patients with PDAC tumors that can't make serine," said lead study author Robert Banh. "Whether this approach could decrease tumor recurrence by limiting the nutrient supply would need to be confirmed in clinical trials."

Sources: Cell, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
AUG 04, 2021
Health & Medicine
Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial
AUG 04, 2021
Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial
  A phase II trial is being planned to test the cannabis-derived drug Sativex, in patients with aggressive brain tu ...
AUG 18, 2021
Technology
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
AUG 18, 2021
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
All cells in a tumor share some genetic similarities, but also have key differences, often hindering effective treatment ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
OCT 14, 2021
Cancer
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
OCT 14, 2021
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
Colorectal cancer develops when a series of changes occur across multiple genes.  While researchers have paid signi ...
Loading Comments...